| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Yu Kitazawa, Yoko Warabi, Mitsuaki Bandoh, Toshiyuki Takahashi, Shiro Matsubar. Elderly-onset neuromyelitis optica which developed after the diagnosis of prostate adenocarcinoma and relapsed after a 23-valent pneumococcal polysaccharide vaccination. Internal medicine (Tokyo, Japan). vol 51. issue 1. 2012-05-24. PMID:22214633. |
we report a case of elderly-onset neuromyelitis optica (nmo) positive for the anti-aquaporin-4 (aqp-4) antibody; symptoms developed after the diagnosis of prostate adenocarcinoma and relapsed after a 23-valent pneumococcal polysaccharide vaccination. |
2012-05-24 |
2023-08-12 |
human |
| Uwe K Zettl, Olaf Stüve, Robert Patejd. Immune-mediated CNS diseases: a review on nosological classification and clinical features. Autoimmunity reviews. vol 11. issue 3. 2012-05-22. PMID:21619943. |
in other, slightly more frequent diseases as neuromyelitis optica (nmo), advances in the concepts of specific biological features have been achieved and are beginning to transform into changes in clinical concepts. |
2012-05-22 |
2023-08-12 |
Not clear |
| Andrea T Borchers, M Eric Gershwi. Transverse myelitis. Autoimmunity reviews. vol 11. issue 3. 2012-05-22. PMID:21621005. |
the combination of atm and optic neuritis characterize devic's syndrome or neuromyelitis optica (nmo). |
2012-05-22 |
2023-08-12 |
Not clear |
| Fernanda C Rueda Lopes, Thomas Doring, Christianne Martins, Fernanda C Cabral, Fabíola R Malfetano, Valéria C S R Pereira, Soniza Alves-Leon, Emerson L Gasparett. The role of demyelination in neuromyelitis optica damage: diffusion-tensor MR imaging study. Radiology. vol 263. issue 1. 2012-05-22. PMID:22438446. |
to test the hypothesis that white matter damage in neuromyelitis optica (nmo) is more extensive than previously described and likely includes involvement of normal-appearing white matter and to explore by using diffusion-tensor (dt) imaging whether white matter lesions are not only related to wallerian degeneration but are also caused by demyelination. |
2012-05-22 |
2023-08-12 |
Not clear |
| Yaou Liu, Peipeng Liang, Yunyun Duan, Xiuqin Jia, Fei Wang, Chunshui Yu, Wen Qin, Huiqing Dong, Jing Ye, Kuncheng L. Abnormal baseline brain activity in patients with neuromyelitis optica: a resting-state fMRI study. European journal of radiology. vol 80. issue 2. 2012-05-18. PMID:20605694. |
recent immunopathologic and mri findings suggest that tissue damage in neuromyelitis optica (nmo) is not limited to spinal cord and optic nerve, but also in brain. |
2012-05-18 |
2023-08-12 |
Not clear |
| Fei Wang, Yaou Liu, Yunyun Duan, KunCheng L. Brain MRI abnormalities in neuromyelitis optica. European journal of radiology. vol 80. issue 2. 2012-05-18. PMID:20884147. |
the purpose of this study was to explore brain mri findings in neuromyelitis optica (nmo) and to investigate specific brain lesions with respect to the localization of aquaporin-4 (aqp-4). |
2012-05-18 |
2023-08-12 |
Not clear |
| Yunyun Duan, Yaou Liu, Peipeng Liang, Xiuqin Jia, Chunshui Yu, Wen Qin, Hui Sun, Zhangyuan Liao, Jing Ye, Kuncheng L. Comparison of grey matter atrophy between patients with neuromyelitis optica and multiple sclerosis: a voxel-based morphometry study. European journal of radiology. vol 81. issue 2. 2012-05-17. PMID:21316170. |
however, whether there is any regional gm atrophy in neuromyelitis optica (nmo) and the difference between nmo and ms is unclear. |
2012-05-17 |
2023-08-12 |
Not clear |
| M H Barnett, J W Prineas, M E Buckland, J D E Parratt, J D Pollar. Massive astrocyte destruction in neuromyelitis optica despite natalizumab therapy. Multiple sclerosis (Houndmills, Basingstoke, England). vol 18. issue 1. 2012-05-17. PMID:21868485. |
auto-antibody mediated astrocyte injury is implicated as a primary event in neuromyelitis optica (nmo) by biomarker, post-mortem and experimental studies that differentiate the condition from multiple sclerosis. |
2012-05-17 |
2023-08-12 |
Not clear |
| N Asgari, C Nielsen, E Stenager, K O Kyvik, S T Lillevan. HLA, PTPN22 and PD-1 associations as markers of autoimmunity in neuromyelitis optica. Multiple sclerosis (Houndmills, Basingstoke, England). vol 18. issue 1. 2012-05-17. PMID:21908482. |
neuromyelitis optica (nmo) is a disease with autoimmune characteristics. |
2012-05-17 |
2023-08-12 |
Not clear |
| Dean M Wingerchuk, Brian G Weinshenke. The emerging relationship between neuromyelitis optica and systemic rheumatologic autoimmune disease. Multiple sclerosis (Houndmills, Basingstoke, England). vol 18. issue 1. 2012-05-17. PMID:22146604. |
neuromyelitis optica (nmo) and nmo spectrum disorders (nmosd) are associated with autoantibodies that target aquaporin-4 and, in many cases, multiple other autoantibodies, including antinuclear antibody and antibodies to extractable nuclear antigens. |
2012-05-17 |
2023-08-12 |
Not clear |
| Lukmanee Tradtrantip, Hua Zhang, Samira Saadoun, Puay-Wah Phuan, Chiwah Lam, Marios C Papadopoulos, Jeffrey L Bennett, A S Verkma. Anti-aquaporin-4 monoclonal antibody blocker therapy for neuromyelitis optica. Annals of neurology. vol 71. issue 3. 2012-05-16. PMID:22271321. |
neuromyelitis optica (nmo) is an inflammatory demyelinating disease of the central nervous system. |
2012-05-16 |
2023-08-12 |
Not clear |
| Samira Saadoun, Patrick Waters, Claire MacDonald, B Anthony Bell, Angela Vincent, A S Verkman, Marios C Papadopoulo. Neutrophil protease inhibition reduces neuromyelitis optica-immunoglobulin G-induced damage in mouse brain. Annals of neurology. vol 71. issue 3. 2012-05-16. PMID:22374891. |
neuromyelitis optica (nmo) is an inflammatory demyelinating disease of the central nervous system associated with pathogenic autoantibodies against the astrocyte water channel protein aquaporin-4 (aqp4). |
2012-05-16 |
2023-08-12 |
mouse |
| P J Waters, A McKeon, M I Leite, S Rajasekharan, V A Lennon, A Villalobos, J Palace, J N Mandrekar, A Vincent, A Bar-Or, S J Pittoc. Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays. Neurology. vol 78. issue 9. 2012-05-15. PMID:22302543. |
neuromyelitis optica (nmo) immunoglobulin g (igg) (aquaporin-4 [aqp4] igg) is highly specific for nmo and related disorders, and autoantibody detection has become an essential investigation in patients with demyelinating disease. |
2012-05-15 |
2023-08-12 |
Not clear |
| Katja Van Herle, Jacinta M Behne, Andre Van Herle, Terrence F Blaschke, Terry J Smith, Michael R Yeama. Integrative continuum: accelerating therapeutic advances in rare autoimmune diseases. Annual review of pharmacology and toxicology. vol 52. 2012-05-03. PMID:22235861. |
an integrative continuum model to address these challenges is being applied to neuromyelitis optica (nmo)-a potentially devastating neurodegenerative process that has had limited therapeutic options. |
2012-05-03 |
2023-08-12 |
Not clear |
| B Bourre, R Marignier, H Zéphir, C Papeix, D Brassat, G Castelnovo, N Collongues, S Vukusic, P Labauge, O Outteryck, B Fontaine, P Vermersch, C Confavreux, J de Sez. Neuromyelitis optica and pregnancy. Neurology. vol 78. issue 12. 2012-05-01. PMID:22402855. |
the purpose of our study was to assess the influence of pregnancy on the course of neuromyelitis optica (nmo) and the impact of epidural analgesia and breastfeeding on its activity in the postpartum period. |
2012-05-01 |
2023-08-12 |
Not clear |
| Mario Habek, Ivan Adamec, Vesna V Brina. Spinal cord tumor versus transverse myelitis. The spine journal : official journal of the North American Spine Society. vol 11. issue 12. 2012-04-26. PMID:22082692. |
longitudinally extensive transverse myelitis (letm) is one of the defining features of neuromyelitis optica (nmo). |
2012-04-26 |
2023-08-12 |
Not clear |
| Ingo Kleiter, Kerstin Hellwig, Achim Berthele, Tania Kümpfel, Ralf A Linker, Hans-Peter Hartung, Friedemann Paul, Orhan Akta. Failure of natalizumab to prevent relapses in neuromyelitis optica. Archives of neurology. vol 69. issue 2. 2012-04-09. PMID:22332191. |
to describe first experiences with the integrin inhibitor natalizumab, given to patients with suspected relapsing-remitting multiple sclerosis (ms) who were later diagnosed with aquaporin 4-positive neuromyelitis optica (nmo). |
2012-04-09 |
2023-08-12 |
Not clear |
| Honghao Wang, Kai Wang, Xiaonan Zhong, Yongqiang Dai, Aimin Wu, Ying Li, Xueqiang H. Plasma sCD28, sCTLA-4 levels in neuromyelitis optica and multiple sclerosis during relapse. Journal of neuroimmunology. vol 243. issue 1-2. 2012-04-05. PMID:22177277. |
however, scd28 and sctla-4 in neuromyelitis optica (nmo) and multiple sclerosis (ms) patients were less studied. |
2012-04-05 |
2023-08-12 |
Not clear |
| J-B Chanson, H Zéphir, N Collongues, O Outteryck, F Blanc, M Fleury, P Vermersch, J de Sez. Evaluation of health-related quality of life, fatigue and depression in neuromyelitis optica. European journal of neurology. vol 18. issue 6. 2012-04-02. PMID:21087360. |
these changes have not been yet measured in neuromyelitis optica (nmo). |
2012-04-02 |
2023-08-12 |
Not clear |
| Klaus Lehmann-Horn, Eva Schleich, Deetje Hertzenberg, Alexander Hapfelmeier, Tania Kümpfel, Nikolas von Bubnoff, Reinhard Hohlfeld, Achim Berthele, Bernhard Hemmer, Martin S Webe. Anti-CD20 B-cell depletion enhances monocyte reactivity in neuroimmunological disorders. Journal of neuroinflammation. vol 8. 2012-03-30. PMID:22027448. |
clinical trials evaluating anti-cd20-mediated b-cell depletion in multiple sclerosis (ms) and neuromyelitis optica (nmo) generated encouraging results. |
2012-03-30 |
2023-08-12 |
Not clear |